...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: I think one major reason that,

"So, why make the combination effect of both as the primary end point!!"

Because current standard of care for diabetic recent ACS patients includes aggressive LDL-C lowering by means of statins and/or other LDL-C lowering therapies.

BDAZ

Share
New Message
Please login to post a reply